论文部分内容阅读
目的:探讨步长脑心通在治疗ICVD(缺血性脑血管病)中的临床综合疗效。方法:选取2008年4月-2013年4月收治的ICVD患者中的120例,分为2组,每组各有60例;对照组采用丹参注射液和胞二磷胆碱治疗,研究组同时使用步长脑心通治疗,比较两组治疗前后神经功能缺失度变化情况乙级临床综合疗效情况。结果:治疗前,两组在神经功能缺失度评分上无明显差别(P>0.05);治疗后研究组神经功能缺失度降低更显著(P<0.05)。另外,研究组总有效率91.7%,显效率36.7%,痊愈率43.3%;对照组总有效率78.3%,显效率23.3%,痊愈率33.3%;研究组患者死亡率1.7%,对照组患者死亡率3.3%。研究组临床综合疗效更显著(P<0.05)。结论:步长脑心通在治疗ICVD中具有显著的临床效果,可实现标本兼治,且安全性高,值得推广应用。
Objective: To investigate the clinical efficacy of Stephenxuetong in the treatment of ICVD (Ischemic Cerebrovascular Disease). Methods: One hundred and twenty ICVD patients who were admitted from April 2008 to April 2013 were divided into two groups (60 in each group). The control group received Salviae miltiorrhiza injection and Citicoline, and the study group The use of step Naoxintong treatment, compared two groups before and after treatment of neurological deficit changes in Class B clinical efficacy. Results: Before treatment, there was no significant difference between the two groups in the score of neurological deficit (P> 0.05). After treatment, the decrease of neurological deficit in the study group was more significant (P <0.05). In addition, the total effective rate was 91.7%, the effective rate was 36.7% and the cure rate was 43.3% in the study group. The total effective rate was 78.3%, the effective rate was 23.3% and the cure rate was 33.3% in the study group. The mortality in the study group was 1.7% 3.3%. The clinical efficacy of the study group was more significant (P <0.05). Conclusion: Stephenxitongtong has significant clinical effect in the treatment of ICVD, which can be used to treat both the symptoms and the root cause, and it is safe and worthy of popularization and application.